Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James F Fries

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|May 1, 1993
Two-year results of a randomized controlled trial of a health promotion program in a retiree population: the Bank of America StudyJames F Fries, Daniel A Bloch, Harry Harrington, et al.
The Journal of Rheumatology|July 2, 2004
Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment QuestionnaireEswar Krishnan, Kirsten Murtagh, Bonnie Bruce, et al.
The Journal of Rheumatology|August 16, 2002
Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effectsStacey Hurst, Michael J Kallan, Frederick J Wolfe, et al.
American Journal of Preventive Medicine|June 14, 2008
Long distance running and knee osteoarthritis. A prospective studyEliza F Chakravarty, Helen B Hubert, Vijaya B Lingala, et al.
Arthritis and Rheumatism|October 10, 2012
Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritisMary Chester M Wasko, Abhijit Dasgupta, Helen Hubert, et al.
Journal of Clinical Epidemiology|October 6, 2009
A first step to assess harm and benefit in clinical trials in one scaleMaarten Boers, Peter Brooks, James F Fries, et al.
Arthritis Care & Research|September 29, 2015
Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease-Modifying Antirheumatic DrugsMary Chester Wasko, Abhijit Dasgupta, Genevieve Ilse Sears, et al.
The Journal of Rheumatology|November 19, 2013
Item response theory, computerized adaptive testing, and PROMIS: assessment of physical functionJames F Fries, James Witter, Matthias Rose, et al.
Arthritis and Rheumatism|August 31, 2004
The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritisJames F Fries, Kirsten N Murtagh, Mihoko Bennett, et al.
Journal of Clinical Epidemiology|April 5, 2014
The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiencyMatthias Rose, Jakob B Bjorner, Barbara Gandek, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|May 1, 1993
Two-year results of a randomized controlled trial of a health promotion program in a retiree population: the Bank of America StudyJames F Fries, Daniel A Bloch, Harry Harrington, et al.
The Journal of Rheumatology|July 2, 2004
Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment QuestionnaireEswar Krishnan, Kirsten Murtagh, Bonnie Bruce, et al.
The Journal of Rheumatology|August 16, 2002
Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effectsStacey Hurst, Michael J Kallan, Frederick J Wolfe, et al.
American Journal of Preventive Medicine|June 14, 2008
Long distance running and knee osteoarthritis. A prospective studyEliza F Chakravarty, Helen B Hubert, Vijaya B Lingala, et al.
Arthritis and Rheumatism|October 10, 2012
Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritisMary Chester M Wasko, Abhijit Dasgupta, Helen Hubert, et al.
Journal of Clinical Epidemiology|October 6, 2009
A first step to assess harm and benefit in clinical trials in one scaleMaarten Boers, Peter Brooks, James F Fries, et al.
Arthritis Care & Research|September 29, 2015
Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease-Modifying Antirheumatic DrugsMary Chester Wasko, Abhijit Dasgupta, Genevieve Ilse Sears, et al.
The Journal of Rheumatology|November 19, 2013
Item response theory, computerized adaptive testing, and PROMIS: assessment of physical functionJames F Fries, James Witter, Matthias Rose, et al.
Arthritis and Rheumatism|August 31, 2004
The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritisJames F Fries, Kirsten N Murtagh, Mihoko Bennett, et al.
Journal of Clinical Epidemiology|April 5, 2014
The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiencyMatthias Rose, Jakob B Bjorner, Barbara Gandek, et al.
Pageof 9